Profile
Full Name
Theravance Biopharma, Inc.Ticker Symbol
TBPHExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 16, 2014Indexes
Not includedWebsite
http://www.theravance.comEmployees
97Key Details
Price
$8.34(-0.60%)
Market cap
$412.58M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$64.38M(+12.12% YoY)
Annual EPS
-$1.15(-15.00% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Theravance Biopharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 27, 25 HC Wainwright & Co.
BuyFeb 25, 25 HC Wainwright & Co.
BuySep 16, 24 HC Wainwright & Co.
BuyAug 6, 24 TD Cowen
HoldAug 6, 24 Leerink Partners
Market PerformAug 6, 24 HC Wainwright & Co.
BuyMay 29, 24 HC Wainwright & Co.
BuyMay 14, 24 HC Wainwright & Co.
BuyApr 12, 24 BTIG
BuyAug 8, 23 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Theravance Biopharma?
- Does Theravance Biopharma pay dividends?
- What sector is Theravance Biopharma in?
- What industry is Theravance Biopharma in?
- What country is Theravance Biopharma based in?
- When did Theravance Biopharma go public?
- Is Theravance Biopharma in the S&P 500?
- Is Theravance Biopharma in the NASDAQ 100?
- Is Theravance Biopharma in the Dow Jones?
- When was Theravance Biopharma's last earnings report?
- When does Theravance Biopharma report earnings?
- Should I buy Theravance Biopharma stock now?
What is the ticker symbol for Theravance Biopharma?
The ticker symbol for Theravance Biopharma is NASDAQ:TBPH
Does Theravance Biopharma pay dividends?
No, Theravance Biopharma does not pay dividends
What sector is Theravance Biopharma in?
Theravance Biopharma is in the Healthcare sector
What industry is Theravance Biopharma in?
Theravance Biopharma is in the Biotechnology industry
What country is Theravance Biopharma based in?
Theravance Biopharma is headquartered in United States
When did Theravance Biopharma go public?
Theravance Biopharma's initial public offering (IPO) was on May 16, 2014
Is Theravance Biopharma in the S&P 500?
No, Theravance Biopharma is not included in the S&P 500 index
Is Theravance Biopharma in the NASDAQ 100?
No, Theravance Biopharma is not included in the NASDAQ 100 index
Is Theravance Biopharma in the Dow Jones?
No, Theravance Biopharma is not included in the Dow Jones index
When was Theravance Biopharma's last earnings report?
Theravance Biopharma's most recent earnings report was on Feb 26, 2025
When does Theravance Biopharma report earnings?
The next expected earnings date for Theravance Biopharma is May 13, 2025
Should I buy Theravance Biopharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions